Nuværende sprog:
- EN English
Partial refusal to give public access to Clinical Studies Reports relating to the approval of a medicinal product (Humira) for the treatment of Crohn's Disease
Sag OI/3/2014/FOR - Indledt den Onsdag | 16 april 2014 - Afgørelse af Onsdag | 08 juni 2016 - Den vedrørte institution Det Europæiske Lægemiddelagentur ( Ikke grund til yderligere undersøgelser ) - Land Frankrig
Partial refusal to give public access to Clinical Studies Reports relating to the approval
of a medicinal product (Humira) for the treatment of Crohn's Disease